Results 51 to 60 of about 9,249 (288)

Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs

Parasites & Vectors, 2020
Background Recent reports indicated that increasing the monthly oral dosage and the number of consecutive monthly doses of moxidectin improved the efficacy against macrocyclic lactone (ML)-resistant Dirofilaria immitis.
Kristina Kryda, Susan Holzmer, William R. Everett, John W. McCall, Sean P. Mahabir, Tom L. McTier, Steven J. Maeder   +6 more
doaj   +1 more source

Strategies for the control of Rhipicephalus microplus ticks in a world of conventional acaricide and macrocyclic lactone resistance [PDF]

, 2018
Infestations with the cattle tick, Rhipicephalus microplus, constitute the most important ectoparasite problem for cattle production in tropical and subtropical regions worldwide, resulting in major economic losses. The control of R.
Bhushan, Chandra, Jonsson, Nicholas N., Rodriguez-Vivas, Roger I.   +2 more
core   +1 more source

Tolerability study of Imidacloprid-Pyriproxyfen-Moxidectin-based drugs in dogs and cats

Russian Journal of Parasitology, 2023
The purpose of the research is to study tolerance of Imidacloprid-Pyriproxyfen-Moxidectin-based drugs for veterinary use by target animal species.Materials and methods.
O. Tochieva, M. Arisov
semanticscholar   +1 more source

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats

Parasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas
Nadja Rohdich, Eva Zschiesche, Oliver Wolf, Wolfgang Loehlein, Thierry Pobel, Maria José Gil, Rainer K. A. Roepke   +6 more
doaj   +1 more source

Poloxamer 407/188 Binary Thermosensitive Gel as a Moxidectin Delivery System: In Vitro Release and In Vivo Evaluation

Molecules, 2022
Moxidectin (MXD) is an antiparasitic drug used extensively in veterinary clinics. In this study, to develop a new formulation of MXD, a thermosensitive gel of MXD (MXD-TG) was prepared based on poloxamer 407/188.
Xiangchun Ruan, Jidong Hu, Lianshou Lu, Youwei Wang, Chunlian Tang, F. Liu, Xiuge Gao, Li Zhang, Hao Wu, Xianhui Huang, Qing Wei   +10 more
semanticscholar   +1 more source

Comparative studies of early season moxidectin treatment and conventional ivermectin/ benzimidazole treatments in the control of cyathostomes in horses

Veterinární Medicína, 2003
Moxidectin administered in January or February at a single dose was tested for efficacy in horses on two farms for 12 and 11 months, respectively. Horses were infected with cyathostomes naturally in the previous grazing period. Forty horses of farm 1 and
I. Langrová, I. Jankovská, M. Borovský   +2 more
doaj   +1 more source

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis

Parasites & Vectors, 2022
Background Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the ...
Nadja Rohdich, Leon Meyer, Frank Guerino
doaj   +1 more source

An Accessible Alternative to Melarsomine: “Moxi-Doxy” for Treatment of Adult Heartworm Infection in Dogs

Frontiers in Veterinary Science, 2021
Canine heartworm infection, caused by the filarial parasite Dirofilaria immitis, represents a serious and expanding animal welfare concern that is expected to increase due to the effects of climate change and the COVID-19 pandemic. A body of evidence has
Linda S. Jacobson, Brian A. DiGangi
doaj   +1 more source

Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves [PDF]

, 2008
A
ALVINERIE, M, BASSISSI, F, Deprez, Piet, Everaert, Dries, Vercruysse, Jozef   +4 more
core   +2 more sources

Praziquantel and Moxidectin pharmacokinetics in dogs after Helmimax administration

Российский паразитологический журнал, 2023
The purpose of the research is to study Praziquantel and Moxidectin pharmacokinetics in dogs after Helmimax administration.Materials and methods. Helmimax pharmacokinetics was studied on 8 adult male dogs of different breeds aged 2 to 5 years and ...
A. A. Smirnov, V. O. Bondarenko, N. I. Soboleva, O. A. Makhlis, A. S. Chagin   +4 more
doaj   +1 more source